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The mechanism that causes the detachment of spermatozoa from the oviductal reservoir around the 6 
time of ovulation remains to be elucidated. Because the cumulus cells of the bovine oocyte are 7 
known to secrete progesterone (P4), and P4 has been shown to act upon cation channels of 8 
spermatozoa (CatSper) in human spermatozoa, it was hypothesised that P4 could induce 9 
hyperactivation due to an influx of extracellular calcium, and this would facilitate detachment of 10 
spermatozoa from oviductal epithelial cells. Therefore, this study aimed to investigate the role and 11 
mechanism of action of P4 in the release of spermatozoa from bovine oviduct epithelial cells (BOEC). 12 
Initial dose–response assessments on sperm hyperactivation determined the optimum 13 
concentration of P4 (10 nM), mibefradil (a non-specific Ca2+ channel antagonist; 5 µM), NNC 55-0396  14 
dihydrochloride (NNC; a CatSper antagonist; 2 µM), mifepristone (a classical and membrane P4 15 
receptor antagonist; 400 nM) and AG205 (a membrane P4 receptor antagonist; 10 μM). BOEC 16 
explants were incubated with frozen–thawed bovine spermatozoa for 30 min, following which 17 
loosely bound spermatozoa were removed. Two experiments were completed. In Experiment 1, 18 
BOECs were treated for 30 min with either no treatment, P4, NNC, mibefradil, P4 + mibefradil, P4 + 19 
NNC, P4 + mibefradil + NNC or P4 + EGTA. In Experiment 2, BOECs were treated for 30 min with 20 
either no treatment, P4, mifepristone, AG205, mifepristone + AG205, P4 + mifepristone, P4 + AG205 21 
or P4 + mifepristone + AG205. The number of spermatozoa remaining bound per square millimetre 22 
of BOEC explant was determined. Progesterone stimulated the release of bound spermatozoa from 23 
BOEC explants, whereas NNC, mibefradil and EGTA inhibited this release. The release of 24 
spermatozoa by P4 was inhibited in the presence of both mifepristone and AG205, whereas the 25 
combination of both had the greatest inhibitory action on P4 release of spermatozoa. These findings 26 
suggest the presence of a P4 membrane receptor on bovine spermatozoa and that P4-induced 27 
release of spermatozoa from BOECs is likely mediated by extracellular Ca2+. 28 
Additional keywords: membrane progesterone receptor, oviduct, progesterone receptor membrane 29 
component 1 (PGRMC1), unbinding. 30 
J. Romero-Aguirregomezcorta et al. 31 
Membrane P4 receptor and bull sperm function 32 
This work offers a novel insight into the effect of progesterone (P4) on bovine sperm hyperactivation 33 
and associated release from the oviductal epithelium. Through investigation of the molecular 34 
mechanism of action of P4 we have demonstrated that hyperactivation induced by P4 plays a role in 35 
the detachment of bovine sperm from oviductal epithelial cells and that the presence of extracellular 36 
Ca²⁺ is essential in this response to P4. These findings increase our understanding of how sperm are 37 
released from reservoirs in the upper female reproductive tract. 38 
Introduction 39 
Formation of a sperm reservoir in the isthmus of the oviducts plays a critical role in maintaining the 40 
fertile lifespan of spermatozoa. Uncapacitated spermatozoa preferentially bind by the plasma 41 
membrane overlying the acrosome to the ciliated surface of epithelial cells (Yanagimachi and Chang 42 
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1963; Lefebvre and Suarez 1996; Fazeli et al. 1999), and bound spermatozoa have been shown to 43 
have low intracellular Ca2+ content, low tyrosine phosphorylation (Gualtieri et al. 2005), intact 44 
acrosomes (Gualtieri and Talevi 2000) and normal chromatin structure (Ellington et al. 1999). Their 45 
gradual release in response to the oviductal microenvironments surrounding bound spermatozoa 46 
supplies the ampulla with a steady supply of functional spermatozoa while minimising the incidence 47 
of polyspermy. The role of sperm capacitation in the detachment of spermatozoa from the oviductal 48 
epithelium has been well described (Gadella and Boerke 2016; Miller 2018). Once capacitated 49 
spermatozoa unbind, they lose their affinity for the oviductal epithelium (Gualtieri et al. 2005). 50 
Moreover, it has been demonstrated that hyperactivation can induce the release of uncapacitated 51 
spermatozoa, and these spermatozoa maintain the ability to rebind (Chang and Suarez 2012). 52 
Indeed, only mouse spermatozoa that exhibit hyperactivated motility detached from the oviductal 53 
epithelium (Demott and Suarez 1992), and those lacking the cation channel of spermatozoa 54 
(CatSper) were unable to hyperactivate and failed to progress beyond the oviductal sperm reservoir 55 
because they remained bound to the oviductal epithelium in vivo (Ho et al. 2009). Hyperactivated 56 
free-swimming spermatozoa demonstrate an asymmetric waveform that results in a helical or 57 
curved trajectory (Yanagimachi 1970), whereas a tethered spermatozoon generates tugging forces 58 
to enable it to detach from a surface (Curtis et al. 2012). Moreover, the attaching and detaching 59 
sequence has not been witnessed with symmetrical flagellar beating spermatozoa (Chang and 60 
Suarez 2012). Thus, it remains unclear whether hyperactivation-induced detachment is the same in 61 
other species and, if so, what triggers the sequential release of spermatozoa through 62 
hyperactivation. 63 
The influx of Ca2+ triggers multiple physiological events in spermatozoa, including hyperactivated 64 
motility (Ho et al. 2002), capacitation and the acrosome reaction (Breitbart 2002; Kirkman-Brown et 65 
al. 2002), each of which are essential for fertilisation. Similar to somatic cells, Ca2+ is sourced either 66 
extracellularly or released from intracellular stores in ejaculated spermatozoa (Publicover et al. 67 
2007), but the mechanisms by which intracellular Ca2+ is released from its stores remain to be 68 
elucidated. Unlike most somatic cells, mature spermatozoa do not possess an endoplasmic reticulum 69 
(ER), which is the chief source of Ca2+, hence Ca2+ is thought to be held by a redundant nuclear 70 
envelope (RNE), which colocalises with the inositol 1,4,5-trisphosphate (IP3) receptor (IP3R) in the 71 
neck region, and the tightly packed mitochondria in the midpiece (for a review, see Costello et al. 72 
2009). Both structures contain calreticulin, a Ca2+ storage protein, and Ca2+ mobilisation from these 73 
stores involves the IP3R and the Ca2+-induced Ca2+ release (CICR) of the ryanodine receptor (RyR). 74 
Conversely, in spermatozoa of many mammals, the sperm-specific Ca2+ channel CatSper controls the 75 
entry of Ca2+ into the spermatozoa (for a review, see Singh and Rajender 2015). However, the 76 
mechanism of CatSper activation in different species has yet to be elucidated. 77 
In human spermatozoa, CatSper can be activated through intracellular alkalisation and progesterone 78 
(P4; Lishko and Kirichok 2010; Tamburrino et al. 2014). P4 is secreted by the cumulus cells of the 79 
oocyte in vivo and in vitro (Mingoti et al. 2002), and has been demonstrated to stimulate biological 80 
responses of human spermatozoa, including Ca2+ influx, tyrosine phosphorylation, extracellular 81 
signal-regulated kinases, chloride efflux and increases in cAMP levels (Falkenstein et al. 1999; Lösel 82 
et al. 2003). Studies suggest that the actions of P4 in inducing hyperactivation and the acrosome 83 
reaction can occur independent of each other through different intracellular pathways (Marquez and 84 
Suarez 2004). P4 stimulation of rapid activities in human spermatozoa, at nanomolar to micromolar 85 
concentrations, is proposed to originate from the cell surface and has been seen, in many cells, to be 86 
mediated through non-classical progestin membrane receptors (Thomas et al. 2009). P4 stimulates 87 
Ca2+ entry in human spermatozoa (Falkenstein et al. 1999) by activating CatSper, and these channels 88 
have been associated with stimulation of hyperactivated motility (Lishko et al. 2011). In porcine 89 
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species, CatSper is present in ejaculated boar spermatozoa, being implicated in the regulation of 90 
sperm motility during capacitation (Vicente-Carrillo et al. 2017), and it has been demonstrated that 91 
sperm release from oviduct epithelial cells is triggered specifically by P4 and involves the action of 92 
CatSper (Machado 2013). In the bull, the mechanism of activation of CatSper remains unclear. 93 
Our group has recently demonstrated that hyperactivation of bovine spermatozoa is dependent on 94 
Ca2+ influx through CatSper (Johnson et al. 2017), but whether the release of bovine spermatozoa 95 
from the oviductal epithelium can be induced by hyperactivation and the role, if any, that P4 may 96 
play in the mechanism by which CatSper activation in bovine spermatozoa induces hyperactivation 97 
and the release of spermatozoa from the oviductal epithelium remain unknown. To this end, the aim 98 
of this study was to investigate the role and mechanism of action of P4 in the release of 99 
spermatozoa from bovine oviduct epithelial cells. 100 
Materials and methods 101 
Chemicals and reagents 102 
Unless stated otherwise, all chemicals and reagents were purchased from Sigma-Aldrich Ireland. 103 
Sperm preparation 104 
Frozen–thawed straws from three different Holstein–Friesian bulls were thawed at 37°C and pooled 105 
to minimise interbull variability. Only samples with a post-thaw motility >60% were used. Sperm 106 
concentration was determined using a Neubauer chamber and samples were diluted to 40 × 106 107 
spermatozoa mL–1 in Tyrode’s albumin lactate pyruvate (TALP) medium. This medium consists of 99 108 
mM NaCl, 3.1 mM KCl, 25 mM NaHCO3, 0.4 mM NaH2PO4, 1.1 mM MgCl2, 2 mM CaCl2, 10 mM 109 
HEPES, 25.4 mM Na lactate, 1 mM Na-pyruvate and 6 mg mL–1 bovine serum albumin (BSA). 110 
Assessment of hyperactivation 111 
Hyperactivation was assessed subjectively using a phase contrast microscope (CX41; Olympus) fitted 112 
with a heated stage (37°C) at a magnification of ×400. Aliquots (200 μL) of treated spermatozoa 113 
were incubated for 10 min in 5% CO2 at 37°C. After incubation, a 10-μL droplet of sample was placed 114 
on a prewarmed slide with a coverslip for evaluation. The percentage hyperactivation in a sample 115 
was determined by assessing the number of hyperactivated spermatozoa from 100 motile sperm 116 
cells assessed. Hyperactivated motility was manifested as characteristic figure-of-eight swimming 117 
trajectories with a helical pattern (Ho et al. 2002), compared with the linear movement of non-118 
hyperactivated spermatozoa. Three technical replicates of each sample were completed (total 300 119 
spermatozoa assessed per replicate) before averaging the percentage hyperactivation per replicate. 120 
All assessments were performed in a blinded manner. This was the method used for all assessments 121 
of hyperactivation in this study. The sperm treatments used are detailed in their relevant 122 
experimental sections below. 123 
Bovine oviductal epithelial cell unbinding assay 124 
Non-pregnant heifer reproductive tracts were retrieved from a commercial abattoir immediately 125 
after the heifers had been killed. Reproductive tracts from different oestrus cycle stages were used 126 
because previous studies have shown that stage does not affect the binding capability of 127 
spermatozoa (Lefebvre et al. 1997; Gwathmey et al. 2003). The tracts were transported at 4–5°C to 128 
the laboratory in Dulbecco’s phosphate-buffered saline (PBS) with Ca2+ and Mg2+ and supplemented 129 
with 0.5% gentamycin. At the laboratory, the oviducts were trimmed free of surrounding connective 130 
tissue, ligated using sterile umbilical cord clamps and sterilised in 70% ethanol for 30 s before being 131 
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washed twice in PBS. Under the laminar flow, a transverse incision was made to separate the isthmic 132 
portion of the oviduct, after which bovine oviductal epithelial cells (BOECs) were isolated from each 133 
oviduct through a mechanical scraping technique using a glass slide (Green et al. 2001). The BOECs 134 
were washed, recollected in 1 mL PBS and were centrifuged at 200g for 1 min at 37°C. The 135 
supernatant was removed after centrifugation and 1 mL M199 culture medium supplemented with 136 
10% fetal bovine serum and 0.5% gentamycin was added to the pellet. The BOECs were then 137 
incubated in a 5% CO2 incubator at 37.5°C for 1 h to allow the formation of everted vesicles with 138 
apical ciliated surfaces orientated outwards (Ignotz et al. 2007). 139 
Sperm samples were stained with a 10 µg mL–1 Hoechst 33342 solution, centrifuged twice at 300g 140 
for 5 min at 37°C and diluted to a concentration of 7.14 × 106 mL–1 using prewarmed TALP medium, 141 
after which they were added to a 24-well plate in 140-μL aliquots. After incubation with M199 142 
culture medium, the BOEC explants were washed and centrifuged at 200g for 5 min at 37°C with PBS 143 
(5 mL). After this centrifugation, the supernatant was discarded, and 20 µL pellet (BOEC explants in a 144 
minimum volume of PBS) was added to each aliquot of spermatozoa in the 24-well plate. 145 
Spermatozoa and BOECs were coincubated for 30 min at 37.5°C and 5% CO2, after which loosely 146 
bound spermatozoa were removed from the samples by gently pipetting through two 75-μL droplets 147 
of TALP. Each sample was assessed for bound sperm density, which confirmed equal binding in all 148 
wells. Then, spermatozoa and BOECs were treated with P4 or the range of either agonists and 149 
antagonists for 30 min at 37.5°C and 5% CO2. After incubation, loosely bound and unbound 150 
spermatozoa were removed by gently pipetting through two 75-μL droplets of TALP. A 10-μL droplet 151 
was then placed on a prewarmed slide and covered with a coverslip. Slides were viewed on a heated 152 
stage (37°C) at ×400 under a combination of transmitted and epifluorescence lighting using a 153 
fluorescent microscope (BX60; Olympus). Ten fields of view were randomly assessed per slide. 154 
Spermatozoa were classified as bound if the sperm head was in contact with the apical surface of 155 
the BOEC (Lyons et al. 2018). A micrometer, placed in the eyepiece of the microscope, was used to 156 
measure the surface area of each explant. Bound sperm density was calculated by quantifying the 157 
number of spermatozoa bound per 0.1 mm2 of the explant surface. The assessor was blinded to the 158 
treatments. One well was assessed per treatment per replicate, where one replicate (n) was one 159 
heifer reproductive tract. 160 
Experiment 1: effects of P4 and extracellular Ca2+ on hyperactivation and detachment from BOEC 161 
explants 162 
The aim of this experiment was to investigate the effect of P4 on hyperactivated motility and 163 
detachment from BOEC explants. 164 
Experiment 1a: effects of P4 and extracellular Ca2+ on hyperactivation 165 
It was hypothesised that P4 would induce hyperactivation and would act through the influx of 166 
extracellular Ca2+. Therefore, the aim of this experiment was to quantify the effect of calcium 167 
agonists and antagonists on spermatozoa exhibiting hyperactivated motility. Experiments were 168 
performed using P4 and the Ca2+ channel antagonists mibefradil and NNC 55-0396 (NNC). Mibefradil 169 
is a Ca2+ channel inhibitor that acts on both L- and T-type channels (Mullins et al. 1998), whereas 170 
NNC is a derivative of mibefradil and is a highly selective T-type Ca2+ channel inhibitor (Li et al. 2005). 171 
Initial dose–response assessments were performed to determine the optimum concentrations of P4, 172 
mibefradil and NNC to induce sperm hyperactivation. Vehicle controls were performed for 173 
treatments dissolved in ethanol (P4) and dimethylsulfoxide (DMSO; NNC). P4 concentrations of 0, 5, 174 
8, 10, 50, 500 nM and 1, 10 and 50 μM were assessed. After 10 min incubation, hyperactivation was 175 
assessed as described above, and three replicates were completed. Because it was hypothesised 176 
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that P4 stimulates hyperactivation through extracellular Ca2+ influx, NNC concentrations were 177 
assessed on the basis of their efficiency to antagonise T-type Ca2+ channels in the presence of 10 nM 178 
P4. Treatments included a no treatment control, 10 nM P4 alone and 10 nM P4 combined with NNC 179 
(500 nM, 1, 2, 10, 20 or 30 μM). Hyperactivation was assessed and three replicates were completed. 180 
Similarly, the concentration of mibefradil was determined based on its ability to suppress the 181 
proposed influx of Ca2+. Treatments included a no treatment control, 10 nM P4 alone and 10 nM P4 182 
combined with mibefradil (10, 100, 500 nM, 1, 5, 10, 20 or 40 μM). Hyperactivation was assessed, 183 
and three replicates were completed. 184 
From each of the three dose–response experiments above, the optimum concentration of each drug 185 
was chosen and assessed in one experiment to confirm their effects. The calcium chelator EGTA was 186 
also used to chelate the Ca2+ in the media. In this series of experiments, the treatment groups 187 
included a no treatment control, 10 nM P4 alone, 2 μM NNC alone, 5 μM mibefradil alone, 10 nM P4 188 
+ 5 μM mibefradil, 10 nM P4 + 2 μM NNC, 10 nM P4 + 5 μM mibefradil + 2 μM NNC and 10 nM P4 + 189 
2.5 mM EGTA. 190 
Experiment 1b: effects of P4 and extracellular Ca2+ on the detachment of bound spermatozoa from 191 
BOECs 192 
It was hypothesised that the incubation of bound spermatozoa with P4 would stimulate a release of 193 
spermatozoa from the BOEC explants due to an influx of extracellular Ca2+. NNC and mibefradil were 194 
used as antagonists of Ca2+ channels. Therefore, the aim of this experiment was to investigate the 195 
action of P4 on the release of bound spermatozoa from BOECs. P4 has been proposed to act upon 196 
CatSper in human spermatozoa (Strünker et al. 2011; Alasmari et al. 2013; Tamburrino et al. 2014) 197 
and because CatSper is a T-type Ca2+ channel in spermatozoa (Darszon et al. 2006), NNC is an 198 
effective antagonist. The following treatments were assessed: a no treatment control, 10 nM P4 199 
alone, 2 μM NNC alone, 5 μM mibefradil alone, 10 nM P4 + 5 μM mibefradil, 10 nM P4 + 2 μM NNC, 200 
10 nM P4 + 5 μM mibefradil + 2 μM NNC and 10 nM P4 + 2.5 mM EGTA. All treatments were 201 
assessed for bound sperm density after treatment as described above, and three replicates were 202 
completed. 203 
Experiment 1c: effects of P4 and extracellular Ca2+ on hyperactivation after detachment from BOECs 204 
This experiment was performed to determine the percentage hyperactivation of spermatozoa 205 
detached from BOECs after the following treatment: no treatment control, 10 nM P4 alone, 2 μM 206 
NNC alone, 5 μM mibefradil alone, 10 nM P4 + 5 μM mibefradil, 10 nM P4 + 2 μM NNC, 10 nM P4 + 5 207 
μM mibefradil + 2 μM NNC and 10 nM P4 + 2.5 mM EGTA. The treatments chosen were the same as 208 
those assessed in Experiments 1a and 1b. For this experiment, after the 30 min incubation of sperm 209 
bound to BOECs with P4 and Ca2+ channel antagonists, a 10-μL aliquot was collected from each well 210 
and the percentage hyperactivation of spermatozoa detached from BOECs was determined as 211 
described above. The assessor was blinded to the treatments being assessed, and four replicates 212 
were completed. 213 
Experiment 2: effects of P4 receptor antagonists on the action of P4 214 
The aim of this experiment was to investigate the mechanism of P4 action on bovine spermatozoa. It 215 
was hypothesised that P4 acts on spermatozoa through non-genomic pathways to initiate the influx 216 
of Ca2+. AG205 is a P4 receptor membrane component 1 (PGRMC1) antagonist (Guo et al. 2016) and 217 
has been used to investigate the involvement of PGRMC1 in numerous cell types, predominantly 218 
from the liver and kidneys and cancerous cells (Peluso et al. 2008; Mir et al. 2012). Mifepristone (RU-219 
486) is an antiprogestin that exerts inhibitory effects on membrane P4 receptor (mPR), as seen in T 220 
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cells (Chien et al. 2009). To examine the possible role of both membrane receptors on bovine 221 
spermatozoa, the effects of P4 receptor antagonists in the presence of P4 were assessed on 222 
hyperactivated spermatozoa and on detached spermatozoa from BOECs. 223 
Experiment 2a: effects of P4 receptor antagonists on P4-induced hyperactivation 224 
The aim of this experiment was to investigate whether P4-induced hyperactivation is mediated 225 
through a membrane-bound P4 receptor. An initial dose–response experiment was performed for 226 
both mifepristone and AG205 and the optimum concentration with the greatest effect on 227 
counteracting the action of P4 on sperm hyperactivation was chosen. A vehicle control was 228 
performed for mifepristone because it was dissolved in DMSO. In the case of mifepristone, the 229 
following treatments were assessed: no treatment control, 10 nM P4 alone and 10 nM P4 + 230 
mifepristone (40 and 400 nM and 4 and 400 μM). In the case of AG205, the following treatments 231 
were assessed: no treatment control, 10 nM P4 alone and 10 nM P4 + AG205 (5, 10, 20, 30 and 40 232 
μM). Hyperactivation responses of spermatozoa were analysed using the methods described above. 233 
From each of the two dose–response experiments above, the optimum concentration of each drug 234 
was chosen and assessed in one experiment to confirm their effects. Treatments included a no 235 
treatment control, 10 nM P4 alone, 400 nM mifepristone alone, 10 μM AG205 alone, 400 nM 236 
mifepristone + 10 μM AG205, 10 nM P4 + 400 nM mifepristone, 10 nM P4 + 10 μM AG205 and 10 237 
nM P4 + 400 nM mifepristone + 10 μM AG205. All treatments were assessed in a blinded manner, 238 
and three replicates were completed. 239 
Experiment 2b: effects of P4 and P4 receptor antagonists on the detachment of spermatozoa from 240 
BOECs 241 
It was hypothesised that the action of P4 in the detachment of spermatozoa from BOECs would be 242 
suppressed through the use of P4 receptor antagonists. Bound spermatozoa were treated with a no 243 
treatment control, 10 nM P4 alone, 400 nM mifepristone alone, 10 μM AG205 alone, 400 nM 244 
mifepristone + 10 μM AG205, 10 nM P4 + 400 nM mifepristone, 10 nM P4 + 10 μM AG205 and 10 245 
nM P4 + 400 nM mifepristone + 10 μM AG205. The number of bound spermatozoa remaining after 246 
each treatment was assessed. The assessor was blinded to the treatments being assessed, and three 247 
replicates were completed. 248 
Experiment 2c: effects of P4 and P4 receptor antagonists on hyperactivation after the detachment of 249 
spermatozoa from BOECs 250 
This experiment was performed to determine the percentage hyperactivation of spermatozoa 251 
detached from BOECs after the following treatments: no treatment control, 10 nM P4 alone, 400 nM 252 
mifepristone alone, 10 μM AG205 alone, 400 nM mifepristone + 10 μM AG205, 10 nM P4 + 400 nM 253 
mifepristone, 10 nM P4 + 10 μM AG205 and 10 nM P4 + 400 nM mifepristone + 10 μM AG205. The 254 
treatments chosen were the same as assessed in Experiments 2a and 2b. For this experiment, after 255 
the 30 min incubation of spermatozoa bound to BOECs with P4 and P4 receptor antagonists, a 10-μL 256 
aliquot was collected from each well and the percentage hyperactivation of the sperm detached 257 
from BOECs was determined as described above. All treatments were assessed in a blinded manner, 258 
and four replicates were completed. 259 
Statistical analysis 260 
All data were examined for normality of distribution and were analysed using IBM SPSS Software, 261 
Version 22 (IBM Corp.). All data were normally distributed and thus univariate analysis of variance 262 
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(ANOVA) was used. Post hoc tests were conducted using the Bonferroni test and two-sided P < 0.05 263 
was considered significant. All results are reported as the mean ± s.e.m. 264 
Results 265 
Experiment 1: effects of P4 and extracellular Ca2+ on hyperactivation and release of bound 266 
spermatozoa from BOECs 267 
Experiment 1a: effects of P4 and extracellular Ca2+ on hyperactivation 268 
Hyperactivated motility developed rapidly when spermatozoa were treated with P4, and there was 269 
an effect of P4 treatments on hyperactivated motility (P < 0.001; Fig. 1). Increasing the concentration 270 
of P4 increased sperm hyperactivation, with peak hyperactivation achieved at a concentration of 10 271 
nM P4 (76.8 ± 3.0%; P < 0.001). The Ca2+ channel antagonists NNC and mibefradil successfully 272 
suppressed P4-induced hyperactivation, with concentrations of 2 μM NNC and 5 μM mibefradil 273 
having the greatest antagonistic effect (P < 0.001; Fig. 2); these concentrations were used for 274 
subsequent experiments. 275 
Experiment 1b: effects of P4 and extracellular Ca2+ on hyperactivation and the release of bound 276 
spermatozoa from BOEC explants 277 
P4 increased sperm hyperactivation (P < 0.001; Fig. 3) and stimulated the release of bound 278 
spermatozoa from BOEC explants (P < 0.001; Fig. 3). Incubation of spermatozoa with the Ca2+ 279 
channel antagonists NNC and mibefradil alone had no effect on sperm hyperactivation (P > 0.05) 280 
compared with control. However, incubation of spermatozoa with NNC and mibefradil alone had an 281 
effect on the release of spermatozoa from BOEC explants (P < 0.01). NNC, mibefradil and EGTA 282 
inhibited P4-induced hyperactivation (P < 0.001) and the release of spermatozoa from BOEC explants 283 
induced by P4 (P < 0.001). The mean size of the vesicles was 0.00453 ± 0.000333 mm2. There were 284 
no significant differences in the size of the vesicles among the different treatment groups (P = 285 
0.176). 286 
Experiment 1c: effects of P4 and extracellular Ca2+ on hyperactivation after detachment from BOECs 287 
We also determined hyperactivation of the spermatozoa detached from BOECs after the different 288 
treatments. P4 alone significantly increased the percentage hyperactivation of spermatozoa released 289 
from BOECs compared with the control group (52.7 ± 5.5% vs 16.0 ± 3.2% respectively; P < 0.001). In 290 
the absence of P4, mibefradil and NNC did not affect hyperactivation (17.7 ± 4.7% and 20.7 ± 3.9% 291 
respectively; P > 0.05). The hyperactivation shown by the spermatozoa released by P4 was inhibited 292 
in the presence of EGTA (21.3 ± 2.2%; P < 0.001), mibefradil (27.0 ± 4.0%; P < 0.001), NNC (17.7 ± 293 
2.3%; P < 0.001) and the combination of both Ca2+ channel antagonists (14.0 ± 4.9%; P < 0.001). 294 
Experiment 2: effects of P4 receptor antagonists on the action of P4 295 
Experiment 2a: effects of P4 receptor antagonists on P4-induced hyperactivation 296 
Both P4 receptor antagonists (AG205 and mifepristone) had an effect on P4-induced hyperactivated 297 
motility (P < 0.001 and P < 0.001 respectively; Fig. 4). All concentrations of AG205 inhibited P4-298 
induced hyperactivation (P < 0.001). Mifepristone (400 nM) had the greatest inhibitory effect against 299 
P4 (P < 0.0001). Therefore, the lowest, most-effective concentrations of 10 μM AG205 (P < 0.0001) 300 
and 400 nM mifepristone (P < 0.0001) were deemed optimum for use in subsequent experiments. 301 
Experiment 2b: effects of P4 and P4 receptor antagonists on hyperactivation and the detachment of 302 
spermatozoa from BOECs 303 
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There was an inhibitory effect of P4 receptor antagonists on sperm hyperactivation (P < 0.001) and 304 
release of spermatozoa from BOEC explants (P < 0.01; Fig. 5). In the absence of P4, mifepristone and 305 
AG205 alone or in combination did not affect hyperactivation (P > 0.05) or the release of 306 
spermatozoa from BOECs (P > 0.05). Hyperactivation and the release of spermatozoa from BOEC 307 
explants induced by P4 were inhibited in the presence of mifepristone (P < 0.001 and P < 0.05 308 
respectively) and AG205 (P < 0.001 and P < 0.05 respectively). The combination of AG205 and 309 
mifepristone had the highest significant effect in inhibiting the actions of P4 on both hyperactivation 310 
and the release of spermatozoa from BOEC explants (P < 0.001 and P < 0.01 respectively). Bound 311 
sperm density was not affected by P4 when incubated with both AG205 and mifepristone compared 312 
with the control (P > 0.05). The mean size of the vesicles was 0.00371 ± 0.00020 mm2. There were no 313 
significant differences in the size of the vesicles among the different treatment groups (P = 0.956). 314 
Experiment 2c: effects of P4 and P4 receptor antagonists on hyperactivation after the detachment of 315 
spermatozoa from BOECs 316 
Hyperactivation of spermatozoa released from BOECs after the different treatments was 317 
determined. P4 alone significantly increased the percentage hyperactivation of spermatozoa 318 
released from BOECs compared with the control group (55.3 ± 7.4% and 13.8 ± 3.4% respectively; P < 319 
0.001). In the absence of P4, mifepristone and AG205 alone or in combination had no effect on 320 
hyperactivation (11.5 ± 3.0%, 12.0 ± 1.7% and 17.0 ± 4.3% respectively; P > 0.05). The 321 
hyperactivation shown by spermatozoa released by P4 was inhibited in the presence of mifepristone 322 
(18.3 ± 8.1%; P < 0.001), AG205 (11.8 ± 3.6%; P < 0.001) and the combination of both P4 receptor 323 
antagonists (19.3 ± 2.2%; P < 0.001). 324 
Discussion 325 
The sequential release of fertile spermatozoa from the oviductal reservoir around the time of 326 
ovulation helps deliver a supply of fertile spermatozoa to the ampulla and increases the chances of 327 
successful fertilisation. Most studies to date have focused on the role of capacitation in the 328 
mediation of sperm release and, to the best of the authors’ knowledge, the present study is the first 329 
published study to assess the effects of P4 on bovine sperm hyperactivation and associated 330 
unbinding from the oviductal epithelium. The main findings of this study were that: (1) 331 
hyperactivation stimulates a significant release of spermatozoa from BOECs; (2) hyperactivation of 332 
bovine spermatozoa can be induced by P4 by a rapid non-genomic action; (3) P4 elicits its effect by 333 
directly or indirectly acting on Ca2+ channels, which facilitates the influx of extracellular Ca2+ into the 334 
cell; and (4) the action of P4 on spermatozoa, which was supressed by P4 receptor antagonists in this 335 
dataset, infers the presence of a P4 membrane receptor. 336 
The physiological factors that trigger the sequential release of spermatozoa from oviductal 337 
reservoirs are not well understood. The attachment of spermatozoa to the lower region of the 338 
isthmus maintains sperm viability and delays sperm capacitation in vivo (Pollard et al. 1991; Chian et 339 
al. 1995). It has been shown that the release mechanism does not affect the number of 340 
carbohydrate binding sites that are present in the oviductal epithelium (Lefebvre et al. 1995); 341 
therefore, the key to release mechanisms is through an alteration to the sperm surface in response 342 
to tract components. The release of spermatozoa from the isthmic epithelium has been reported to 343 
be dependent on sperm changes associated with capacitation (Bosch et al. 2001). In the present 344 
study, hyperactivation alone was sufficient for sperm detachment from the isthmic portion of the 345 
oviduct, indicating that hyperactivation is an important sperm release mechanism, in addition to 346 
capacitation. This supports the suggestion that sperm transport involves a cycle of detachment and 347 
attachment in the oviduct before capacitation but, once capacitated, spermatozoa lose their affinity 348 
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for the oviductal epithelium (Lefebvre and Suarez 1996; Gualtieri et al. 2005). Studies of tethered 349 
spermatozoa show that hyperactivated spermatozoa can exert enough propulsive force to penetrate 350 
through viscoelastic fluids and detach from a surface (Ishijima 2011; Curtis et al. 2012). P4 is known 351 
to be released by the cumulus cells of the bovine oocyte (Mingoti et al. 2002), therefore 352 
spermatozoa are exposed to a P4 gradient with maximal concentrations in close proximity to the 353 
oocyte. In the present study a concentration of 10 nM P4 was used, which may be higher than 354 
physiological concentrations to which spermatozoa are exposed to in the female reproductive tract. 355 
This and similar concentrations have been used in functional studies of human spermatozoa (Luconi 356 
et al. 1998; Strünker et al. 2011; Sumigama et al. 2015), with picomolar concentrations used to 357 
demonstrate chemotaxis (Villanueva-Díaz et al. 1995; Teves et al. 2009), whereas the induction of 358 
the acrosome reaction in human spermatozoa has been performed using micromolar concentrations 359 
(Blackmore et al. 1991; Bronson et al. 1999; Kirkman-Brown et al. 2002; Baldi et al. 2009). To date, 360 
much of the focus of the effect of P4 on bovine spermatozoa has been on its ability to induce 361 
chemotaxis (Gil et al. 2008), yet the effect of P4 in the induction of bovine sperm release from the 362 
oviductal reservoir has not been assessed. 363 
This study has shown the positive effect of P4 in the induction of hyperactivation of bovine 364 
spermatozoa, which enabled us to test the hypothesis that hyperactivated motility is responsible for 365 
sperm detachment from oviductal epithelial cells. It has been shown in human spermatozoa that P4 366 
activates a biphasic response, involving repeated intracellular Ca2+ oscillations of a rapid Ca2+ rise, 367 
followed by a sustained increase that is thought to be a result of intracellular Ca2+ store mobilisation 368 
(Harper et al. 2004; Kirkman-Brown et al. 2004). The intracellular Ca2+ concentration is 369 
approximately 30–50 nM in a normal motile bovine spermatozoon, and increases to 200–1000 nM in 370 
a hyperactivated sperm cell (Ho et al. 2002). We demonstrated that hyperactivation induced by P4 371 
occurs rapidly and is reliant on the function of the primary Ca2+ channel in spermatozoa, CatSper. 372 
The importance of Ca2+ influx via CatSper has been illustrated by CatSper-null mice, which are unable 373 
to progress beyond the sperm reservoir (Ho et al. 2009) and have been found to be infertile (Ren et 374 
al. 2001; Carlson et al. 2005; Qi et al. 2007). CatSper has been reported in human (Strünker et al. 375 
2011), mouse (Ren et al. 2001), stallion (Loux et al. 2013) and bovine (Johnson et al. 2017) 376 
spermatozoa and can be antagonised by mibefradil (a non-specific Ca2+ channel blocker) and more 377 
specifically by its derivative NNC, which is less cytotoxic to the spermatozoa (Bui et al. 2008). These 378 
antagonists suppress the effect of P4, demonstrating that P4 acts by stimulating an influx of 379 
extracellular Ca2+ into the cell. When Ca2+ was removed from the medium through the use of EGTA, 380 
the action of P4 was also nullified. Therefore, the presence of extracellular Ca2+ may be essential for 381 
P4 to elicit its effect on hyperactivation and its resultant release of spermatozoa from BOEC 382 
explants. 383 
Interestingly, hyperactivation and the release of spermatozoa from BOEC explants was induced by 384 
P4 but was suppressed by P4 receptor antagonists mifepristone and AG205 when used alone or in 385 
combination. The rapid action of P4 on spermatozoa indicates that P4 acts through a non-genomic 386 
mechanism on the transcriptional and translationally silent cell. The action of AG205 against a non-387 
classical P4 receptor PGRMC1 in this study suggests the presence of this receptor in bovine 388 
spermatozoa. This receptor, part of the membrane-associated progesterone receptor (MAPR) family, 389 
has been located in human and porcine spermatozoa with a molecular mass of approximately 28 kDa 390 
(Lösel et al. 2005; Thomas 2008). In addition, treatment with mifepristone blocked the action of P4 391 
in spermatozoa. Mifepristone has been shown to antagonise both nuclear and membrane P4 392 
receptors (Chabbert-Buffet et al. 2005; Chien et al. 2009), but because the classical P4 receptors 393 
have not been detected in spermatozoa (Baldi et al. 2009) the suppression of P4 hyperactivation by 394 
mifepristone must occur through the inhibition of an mPR on bovine spermatozoa. 395 
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This study, as well as previous work in human spermatozoa (Lishko et al. 2011; Strünker et al. 2011), 396 
suggests that P4 acts through non-genomic pathways by stimulating CatSper. The fast action of P4 397 
on sperm hyperactivation and the demonstrated requirement of extracellular Ca2+ to elicit the 398 
response strongly suggest a direct extracellular effect of P4 on a sperm membrane protein. 399 
Interestingly, it has been found that P4 is more effective on the cell when it is present in the 400 
extracellular milieu than when P4 is microinjected into the cytoplasm (Maller and Krebs 1977). It is 401 
therefore proposed that the action of P4 on a surface receptor may trigger an influx of extracellular 402 
Ca2+ through CatSper (rapid rise), followed by a further CICR from intracellular stores (transient rise) 403 
and stimulation of an intracellular pathway (i.e. phosphatidylinositol 3-kinase/AKT), meaning 404 
phosphorylation of proteins in the sperm cell and thus leading to hyperactivated motility and the 405 
development of the propulsive force to detach from the epithelial cells of the oviduct. Through this 406 
proposed mechanism, the sperm cell still holds the essential surface molecules to reattach to the 407 
oviduct cells on its journey to the oocyte. 408 
In conclusion, this novel study has demonstrated that hyperactivation induced by P4 plays a role in 409 
the detachment of bovine spermatozoa from BOEC explants, which is an indication of events 410 
occurring in vivo. These findings indicate that the presence of extracellular Ca2+ would be essential 411 
for the sperm response to P4. In addition, we have presented evidence that the action of P4 is 412 
mediated by a membrane P4 receptor, but the underlying mechanism that transduces the action of 413 
P4 to intracellular pathways remains to be elucidated. Dissecting the physiological components of 414 
the oviductal environment and their effects on sperm function will expand our understanding of 415 
sperm binding, sequential release and their availability in a sufficient number at the site of 416 
fertilisation close to the time of ovulation. This will lead to an optimisation of the use of semen 417 
during AI, for example by reducing the sperm concentration per straw and thus increasing the 418 
availability of straws of elite bulls. 419 
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Fig. 1. Proportion of spermatozoa exhibiting hyperactivated motility following incubation with 625 
progesterone (P4). Data are the mean ± s.e.m. (n = 3). **P < 0.01, ***P < 0.001 compared with 626 
control. 627 
Fig. 2. Percentage of hyperactivated spermatozoa following incubation with 10 nM progesterone 628 
(P4) alone or in the presence of different concentrations of (a) NNC 55-0396  dihydrochloride (NNC) 629 
or (b) mibefradil. Data are the mean ± s.e.m. (n = 3). Different letters above columns indicate 630 
significant differences (P < 0.05). 631 
Fig. 3. (a) Hyperactivated motility and (b) release of spermatozoa from bovine oviduct epithelial 632 
cell explants of frozen–thawed bovine spermatozoa treated with 10 nM progesterone (P4) alone or 633 
in the presence of the calcium channel antagonists NNC 55-0396  dihydrochloride (NNC; 2 µM) and 634 
mibefradil (5 µM) or the calcium chelator EGTA (2.5 µM). Data are the mean ± s.e.m. (n = 3). 635 
Different letters above columns indicate significant differences (P < 0.05). 636 
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Fig. 4. Sperm hyperactivation following incubation with 10 nM progesterone (P4) alone or in the 637 
presence of different concentrations of the P4 receptor antagonists (a) AG205 or (b) mifepristone. 638 
Data are the mean ± s.e.m. (n = 3). Different letters above columns indicate significant differences (P 639 
< 0.05). 640 
Fig. 5. (a) Hyperactivated motility and (b) release of spermatozoa from bovine oviduct epithelial 641 
cell explants of frozen–thawed bovine spermatozoa treated with 10 nM progesterone (P4) alone or 642 
in the presence of the P4 receptor antagonists AG205 (10 µM) and mifepristone (400 nM). Data are 643 
the mean ± s.e.m. (n = 3). Different letters above columns indicate significant differences (P < 0.05). 644 
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